Search Results
Optimizing Novel HER2-Targeted Therapies and Other Agents in Gastric Cancer Care
Personalizing Gastric Cancer Care With HER2-Targeted and Other Novel Therapies
Optimizing Precision Medicine in Gastric Cancer Care
Chair's Take: HER2-Targeted and Other Agents for Gastric Cancer
Novel targeted therapies for NSCLC: Exploring HER2 dysregulation
New Agents in Gastric Cancer
Taking Aim at GI Cancers With Personalized HER2 and Other Molecularly Targeted Therapies
Treatment of HER2+ NSCLC - 2022 Program: Targeted Therapies Forum
38 Second Line & Later Therapy for HER2+
Dr. Mehta on the Current Treatment Paradigm in HER2-Positive Gastric Cancer
CPP Panel: Targeted Therapy Toxicities and Management - K. Chen, A. Faso & B. Patel - 20240717
Novel Non Immunotherapy Targets and Agents in Gastroesophageal Cancer